Publisher： Future Science
Founded in： 2009
Total resources： 9
E-ISSN： 1756-8927
ISSN： 1756-8927
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Future Medicinal Chemistry
Menu
Future treatment strategies for novel Middle East respiratory syndrome coronavirus infection
By Adedeji Adeyemi O,Sarafianos Stefan G in (2013)
Future Medicinal Chemistry , Vol. 5, Iss. 18, 2013-12 , pp.
Access to resources
Recommend
Flavaglines: potent anticancer drugs that target prohibitins and the helicase eIF4A
By Basmadjian Christine,Thuaud Frédéric,Ribeiro Nigel,Désaubry Laurent in (2013)
Future Medicinal Chemistry , Vol. 5, Iss. 18, 2013-12 , pp.Active site and allosteric inhibitors of the ribonuclease H activity of HIV reverse transcriptase
By Corona Angela,Masaoka Takashi,Tocco Graziella,Tramontano Enzo,Le Grice Stuart FJ in (2013)
Future Medicinal Chemistry , Vol. 5, Iss. 18, 2013-12 , pp.Arylsulfone-based HIV-1 non-nucleoside reverse transcriptase inhibitors
By Famiglini Valeria,Coluccia Antonio,Brancale Andrea,Pelliccia Sveva,La Regina Giuseppe,Silvestri Romano in (2013)
Future Medicinal Chemistry , Vol. 5, Iss. 18, 2013-12 , pp.Pharmaceutical implications of helix length control in helix-mediated protein–protein interactions
By Milroy Lech-Gustav,Brunsveld Luc in (2013)
Future Medicinal Chemistry , Vol. 5, Iss. 18, 2013-12 , pp.By Vhuiyan Mynol,Thomas Dylan,Hossen Farhad,Frankel Adam in (2013)
Future Medicinal Chemistry , Vol. 5, Iss. 18, 2013-12 , pp.By Lanning Maryanna,Fletcher Steven in (2013)
Future Medicinal Chemistry , Vol. 5, Iss. 18, 2013-12 , pp.Naturally occurring plant polyphenols as potential therapies for inherited neuromuscular diseases
By Fuller Heidi R,Humphrey Emma L,Morris Glenn E in (2013)
Future Medicinal Chemistry , Vol. 5, Iss. 17, 2013-11 , pp.
Previous
Next